DJ Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slumped 0.72% to $4.14 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.62% to 19,736.69 and Dow Jones Industrial Average falling 0.54% to 44,401.93.
Inovio Pharmaceuticals Inc. closed $10.61 below its 52-week high ($14.75), which the company reached on April 1st.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.19% to $149.60, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 1.44% to $26.10.
Trading volume (570,211) eclipsed its 50-day average volume of 369,816.
Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 09, 2024 17:27 ET (22:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments